Comparison among homemade repellents made with cloves, picaridin, andiroba, and soybean oil against Aedes aegypti bites

Universidade Estadual Paulista Faculdade de Medicina de Botucatu Departamento de Dermatologia e RadioterapiaUniversidade Estadual Paulista Instituto de Biociências Departamento de ParasitologiaUniversidade Estadual Paulista Faculdade de Medicina de Botucatu Departamento de Dermatologia e RadioterapiaUniversidade Estadual Paulista Instituto de Biociências Departamento de Parasitologi

Neural complications and physical disabilities in leprosy in a capital of northeastern Brazil with high endemicity

INTRODUCTION: Leprosy is an infectious disease whose etiologic agent is Mycobacterium leprae, manifested by dermatological and neurological signs and symptoms. OBJECTIVE: To investigate neural changes and the degree of physical disability in the eyes, hands and feet before and after treatment, as well as sociodemographic and clinical profile of patients affected by leprosy. METHOD: A longitudinal epidemiological study comprising 155 patients with leprosy, from a spontaneous demand, diagnosed between March 2010 and February 2011, and treated with multidrug therapy (MDT) between March 2010 and July 2012 in a program for leprosy eradication in São Luis (MA), Brazil. RESULTS: Before treatment, 46.5% of patients were considered as borderline, 51.6% had some alteration in the eyes and 52.3% in the feet, and the radial nerve (18.7%) was the most affected. There was a statistically significant difference between the changes in the radial nerve at the beginning of and after treatment. CONCLUSIONS: The analysis points to late diagnosis, as some patients have had abnormal neural and physical disabilities before treatment

Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016

© 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license Background: Stroke is a leading cause of mortality and disability worldwide and the economic costs of treatment and post-stroke care are substantial. The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) provides a systematic, comparable method of quantifying health loss by disease, age, sex, year, and location to provide information to health systems and policy makers on more than 300 causes of disease and injury, including stroke. The results presented here are the estimates of burden due to overall stroke and ischaemic and haemorrhagic stroke from GBD 2016. Methods: We report estimates and corresponding uncertainty intervals (UIs), from 1990 to 2016, for incidence, prevalence, deaths, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs). DALYs were generated by summing YLLs and YLDs. Cause-specific mortality was estimated using an ensemble modelling process with vital registration and verbal autopsy data as inputs. Non-fatal estimates were generated using Bayesian meta-regression incorporating data from registries, scientific literature, administrative records, and surveys. The Socio-demographic Index (SDI), a summary indicator generated using educational attainment, lagged distributed income, and total fertility rate, was used to group countries into quintiles. Findings: In 2016, there were 5·5 million (95% UI 5·3 to 5·7) deaths and 116·4 million (111·4 to 121·4) DALYs due to stroke. The global age-standardised mortality rate decreased by 36·2% (−39·3 to −33·6) from 1990 to 2016, with decreases in all SDI quintiles. Over the same period, the global age-standardised DALY rate declined by 34·2% (−37·2 to −31·5), also with decreases in all SDI quintiles. There were 13·7 million (12·7 to 14·7) new stroke cases in 2016. Global age-standardised incidence declined by 8·1% (−10·7 to −5·5) from 1990 to 2016 and decreased in all SDI quintiles except the middle SDI group. There were 80·1 million (74·1 to 86·3) prevalent cases of stroke globally in 2016; 41·1 million (38·0 to 44·3) in women and 39·0 million (36·1 to 42·1) in men. Interpretation: Although age-standardised mortality rates have decreased sharply from 1990 to 2016, the decrease in age-standardised incidence has been less steep, indicating that the burden of stroke is likely to remain high. Planned updates to future GBD iterations include generating separate estimates for subarachnoid haemorrhage and intracerebral haemorrhage, generating estimates of transient ischaemic attack, and including atrial fibrillation as a risk factor. Funding: Bill & Melinda Gates Foundatio

Estudo comparativo das representações sociais sobre diabetes mellitus e pé diabético

The study aimed to investigate social representations of the terms diabetes and diabetic foot in different populations. Participants were divided into groups: diabetics (GD); non- diabetics (GN); and non-diabetic healthcare professionals (GP). Personal data were collected, and subjects answered two questions that were expected to evoke five words that came to mind when they thought of diabetes and then diabetic foot. The evoked material was analyzed with the software Ensemble de Programmes Permettant l'Analyse dês Èvocations. A total of 161 subjects participated, including GD (n = 72) with a mean age of 56.12 ± 5.49 years; GN (n = 38) with a mean age of 54.29 ± 7.91 years; and GP (n = 51) with 34.95 ± 7.52 years. The term diabetes evoked 297 words in GD, 172 in GN, and 235 words in GP. The term diabetic foot evoked 180 words in GD, 90 in GN, and 236 in GP. The groups proved to be anxious for more information, thus confirming the need for awareness-raising and educational programs on diabetes, covering comprehensive issues concerning the disease.O estudo objetivou investigar a representação social dos termos diabetes e pé diabético em diferentes populações. Os participantes foram divididos em grupos: diabético (GD); não-diabético (GN); e profissional da área da saúde nãodiabético (GP). Foram coletados os dados pessoais e os sujeitos responderam a duas perguntas nas quais deveriam evocar cinco palavras que viessem à mente quando pensassem em diabetes e, depois, em pé diabético. O material evocado foi analisado pelo software Ensemble de Programmes Permettant l'Analyse dês Èvocations. Participaram 161 sujeitos, sendo GD (n = 72) com idade média de 56,12 ± 5,49 anos; GN (n = 38) com 54,29 ± 7,91 anos; e GP (n = 51) com idades de 34,95 ± 7,52 anos. Para a representação social do termo diabetes foram evocadas 297 palavras no GD, 172 no GN e 235 palavras no GP. Para o termo pé diabético foram evocadas 180 palavras no GD, 90 no GN e 236 no GP. Os grupos mostraram-se sedentos por maiores informações, confirmando a necessidade de programas de conscientização e educação em diabetes, que contemplem questões globalizantes acerca da doença.Se realizó un estudio para investigar la representación social de los términos diabetes y pie diabético en diferentes poblaciones. Los participantes fueron divididos en grupos: diabéticos (GD), no diabéticos (GN), y profesional de la salud no diabéticos (GP). Se recogieron datos de carácter personal y los sujetos respondieron a dos preguntas en las que cinco evocan las palabras que vienen a la mente cuando se piensa en diabetes y luego en pie diabético. El material se analizó mediante software Ensemble de Programmes Permettant l'Analyse dês Èvocations. Participaron 161 sujetos con GD (n = 72) con una edad media de 56,12 ± 5,49 años, GN (n = 38) con 54,29 ± 7,91 años y GP (n = 51) de 34 años 95 ± 7,52 años. Para la representación social del término diabetes se evocaron en GD 297 palabras, 172 y 235 en el GP GN. Pie diabético se mencionó en los GD 180 palabras, 90 y 236 en el GP GN. Los grupos solicitaban más información, lo que confirma la necesidad de programas de sensibilización y educación sobre la diabetes, que tienen preguntas sobre la globalización de la enfermedad.União Nacional das Instituições de Ensino Superior Privadas Faculdade de Presidente VenceslauUniversidade Estadual Paulista Faculdade de Ciências e TecnologiaUniversidade Estadual Paulista Faculdade de Ciências e Tecnologi

Deterioração controlada para avaliar o potencial fisiológico de sementes de beterraba

Sementes de hortaliças quase sempre apresentam elevado valor comercial, motivo pelo qual devem ter o potencial fisiológico eficientemente avaliado. O teste de deterioração controlada é um dos recomendados para avaliação do vigor de sementes pequenas, como as de beterraba. O objetivo do trabalho foi determinar o melhor procedimento para a condução de referido teste em sementes de beterraba e sua relação com a emergência de plântulas em campo. Foram utilizados sete lotes de sementes da cultivar Top Tall Early Wonder, adquiridos no comércio. Após lavagem em água corrente, as sementes foram submetidas aos testes de germinação, velocidade de germinação, envelhecimento acelerado, emergência de plântulas em campo, velocidade de emergência e deterioração controlada (temperaturas de 41 e 45ºC, teores de água de 22, 24 e 26% e períodos de exposição de 12, 24 e 36 horas). As combinações 41ºC/24%/12 h, 41ºC/24%/36 h, 41ºC/26%/36 h e 45ºC/24%/24 h apresentaram potencial para uso na avaliação do vigor de sementes de beterraba. No entanto, sob as combinações de 41°C/24%/12 h ou 45°C/24%/24 h reduziu-se o tempo de condução do teste.Seeds of vegetable crop species always present high commercial value, so the physiological potential must be efficiently evaluated. The controlled deterioration is a recommended test to evaluate seed vigor of small-seeded vegetable crops, such as beetroot seeds. This research was run in order to determine the best controlled deterioration test procedures for beetroot seeds and its relationship with field seedling emergence. Seven commercial seed lots of the cultivar Top Tall Early Wonder were used. After washing in running water, the seeds were tested for germination, speed of germination, accelerated aging, seedling field emergence, emergence rate and controlled deterioration (41 and 45°C, moisture contents of 22, 24 and 26% and exposure times of 12, 24 and 36 hours). The combination of 41°C/24%/12 hours, 41°C/24%/36 hours, 41°C/26%/36 hours and 45°C/24%/24 hours showed potential to evaluate vigor of beetroot seeds. However, the combinations of 41°C/24%/12 hours or 45°C/24%/24 hours decreased the conduction time of the test

Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017

Background Although the burden of influenza is often discussed in the context of historical pandemics and the threat of future pandemics, every year a substantial burden of lower respiratory tract infections (LRTIs) and other respiratory conditions (like chronic obstructive pulmonary disease) are attributable to seasonal influenza. The Global Burden of Disease Study (GBD) 2017 is a systematic scientific effort to quantify the health loss associated with a comprehensive set of diseases and disabilities. In this Article, we focus on LRTIs that can be attributed to influenza.Methods We modelled the LRTI incidence, hospitalisations, and mortality attributable to influenza for every country and selected subnational locations by age and year from 1990 to 2017 as part of GBD 2017. We used a counterfactual approach that first estimated the LRTI incidence, hospitalisations, and mortality and then attributed a fraction of those outcomes to influenza.Findings Influenza LRTI was responsible for an estimated 145 000 (95% uncertainty interval [UI] 99 000–200 000) deaths among all ages in 2017. The influenza LRTI mortality rate was highest among adults older than 70 years (16·4 deaths per 100 000 [95% UI 11·6–21·9]), and the highest rate among all ages was in eastern Europe (5·2 per 100 000 population [95% UI 3·5–7·2]). We estimated that influenza LRTIs accounted for 9 459 000 (95% UI 3 709 000–22 935 000) hospitalisations due to LRTIs and 81 536 000 hospital days (24 330 000–259 851 000). We estimated that 11·5% (95% UI 10·0–12·9) of LRTI episodes were attributable to influenza, corresponding to 54 481 000 (38 465 000–73 864 000) episodes and 8 172 000 severe episodes (5 000 000–13 296 000).Interpretation This comprehensive assessment of the burden of influenza LRTIs shows the substantial annual effect of influenza on global health. Although preparedness planning will be important for potential pandemics, health loss due to seasonal influenza LRTIs should not be overlooked, and vaccine use should be considered. Efforts to improve influenza prevention measures are neede

Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study

BACKGROUND: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. METHODS: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. RESULTS: GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. CONCLUSIONS: GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future